Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2005 pubmed 47 citations

Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus.

Samuelsen. Orjan O; Haukland. Hanne H HH; Jenssen. Håvard H; Krämer. Manuela M; Sandvik. Kjersti K; Ulvatne. Hilde H; Vorland. Lars H LH

Key Findings

  • Repeated exposure to lactoferricin B can induce resistance in Staph aureus
  • The induced resistance is unstable and drops off without the peptide
  • No cross‑resistance to the human cathelicidin LL‑37 was observed

Practical Outcomes

  • For DIY health enthusiasts, this suggests that using LL‑37 as an antimicrobial is less likely to drive bacterial resistance, but relying on lactoferricin B could lead to temporary resistance. Rotate or limit exposure to lactoferricin B to avoid reduced effectiveness.

Summary

The study found that Staph bacteria can become resistant to the antimicrobial peptide lactoferricin B when repeatedly exposed, but this resistance fades when the peptide is removed and the bacteria do not become resistant to the human peptide LL‑37.

Abstract

This study was designed to investigate inducible intrinsic resistance against lactoferricin B in Staphylococcus aureus. Serial passage of seven S. aureus strains in medium with increasing concentrations of peptide resulted in an induced resistance at various levels in all strains. The induced resistance was unstable and decreased relatively rapidly during passages in peptide free medium but the minimum inhibitory concentration remained elevated after thirty passages. Cross-resistance to penicillin G and low-level cross-resistance to the antimicrobial peptides indolicidin and Ala(8,13,18)-magainin-II amide [corrected] was observed. No cross-resistance was observed to the human cathelicidin LL-37. In conclusion, this study shows that S. aureus has intrinsic resistance mechanisms against antimicrobial peptides that can be induced upon exposure, and that this may confer low-level cross-resistance to other antimicrobial peptides.

Study Information

Provider

pubmed

Year

2005

Date

2005-06-20T00:00:00.000Z

DOI

10.1016/j.febslet.2005.05.017

Citations

47

References

41